Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study on the use of sarilumab in patients with COVID-19 infection
2020-001745-40Phase 2Terminated
- Sponsor
- ASST Fatebenefratelli Sacco
- Start
- Jun 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sarilumab in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by ASST Fatebenefratelli Sacco. Primary endpoint: Improvement in respiratory function. Started Jun 2020; status: terminated.
02
Drugs
sarilumab
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on 2020-001745-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001745-40.